Abstract: The present disclosure generally relates to the utilization of context information by an electronic device. In one example, a context affordance associated with a contextual category is displayed. In response to detecting an input, a plurality of options associated with the contextual category are displayed, including a first option corresponding to a first status that is a current status for the contextual category and a second option corresponding to a second status that is not the current status for the contextual category. When an input is detected that corresponds to the second option of the first plurality of options, the current status for the contextual category is set to the second status.

Abstract: The present disclosure relates to techniques for techniques for including a physical object in a computer-generated reality environment. A context associated with the computer-generated reality environment is identified and a physical object located in a real environment is detected. If the detected physical object is associated with the context of the computer-generated reality environment, then the computer-generated reality environment is displayed with a representation of the physical object inserted into the computer-generated reality environment.

Abstract: A backpack spreader capable of spreading particulate matter in wide and pinpoint spray patterns. The spreader consists of a hopper having an outlet port, the hopper for holding chemical materials therein, and including a mechanism for agitating chemical materials therein, so as to keep chemical materials from sticking together. The agitation mechanism includes a main double ratchet assembly mounted within said hopper adjacent the outlet port. A hollow barrel is connected to the outlet port, the hollow barrel including aperture vanes. A manually-operated ring is externally mounted to the hollow barrel for adjusting the aperture vanes. The hopper is mountable on a back of a person. A flexible feed tube has a first end connected to the outlet port of the hopper. A dispensing gun is connected to a second end of the flexible feed tube, and is held and operated by a hand of the person.

Abstract: A retention harness for restraining a user within a vehicle. The harness includes a waist strap, a waist strap buckle assembly, two over the shoulder straps, a rear connector, and a forward connector. The waist strap is attachable to the waist strap buckle assembly. Each over the shoulder strap is attached to the waist strap buckle assembly. The two over the shoulder straps form an X on a user's back via a shoulder strap crossover plate, while each over the shoulder strap is adjustable via an adjustment slider. The rear connector is attached to the waist strap, and is attachable to retention hardware. The retention hardware is attachable to a bar attached to the vehicle. The forward connector is attached to the waist strap buckle assembly and attachable to forward retention hardware, the forward retention hardware attachable to the vehicle.

Abstract: A retention harness for restraining a user within a vehicle. The harness includes a waist strap, a waist strap buckle assembly, two over the shoulder straps, a rear connector, and a forward connector. The waist strap is attachable to the waist strap buckle assembly. Each over the shoulder strap is attached to the waist strap buckle assembly. The two over the shoulder straps form an X on a user's back via a shoulder strap crossover plate, while each over the shoulder strap is adjustable via an adjustment slider. The rear connector is attached to the waist strap, and is attachable to retention hardware. The retention hardware is attachable to a bar attached to the vehicle. The forward connector is attached to the waist strap buckle assembly and attachable to forward retention hardware, the forward retention hardware attachable to the vehicle.

Abstract: The present disclosure relates to emergency services and more particularly, to a temporary callback system for emergency calls and methods thereof. In one illustrative embodiment, the system can include a private branch exchange (PBX) or other processing device having a pool of callback identities. When an emergency call is made, a callback identity can be temporarily assigned to the device making the call. The callback identity can provide insurance that the call is maintained. If the call between the device and answering point becomes abandoned or disconnected, the callback identity can be used to re-establish the connection. The callback identity can be released when cleared by the answering point or when a time limit expires. After being released, the callback identity can be made available to other devices that wish to make emergency calls.

Abstract: The present disclosure relates to emergency services and more particularly, to a temporary callback system for emergency calls and methods thereof. In one illustrative embodiment, the system can include a private branch exchange (PBX) or other processing device having a pool of callback identities. When an emergency call is made, a callback identity can be temporarily assigned to the device making the call. The callback identity can provide insurance that the call is maintained. If the call between the device and answering point becomes abandoned or disconnected, the callback identity can be used to re-establish the connection. The callback identity can be released when cleared by the answering point or when a time limit expires. After being released, the callback identity can be made available to other devices that wish to make emergency calls.

Abstract: Method of detecting a fault within a redundant communication network including transmitting a first stream of monitoring frames from its main interface PA destined for its standby interface PB, transmitting a second stream of monitoring frames from its standby interface PB destined for its main interface PA, and decision step determining connectivity of the communication network.

Abstract: The present invention relates to a novel BAIT protein which is a member of serpin superfamily which is expressed primarily in brain tissue. In particular, isolated nucleic acid molecules are provided encoding the human and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of BAIT activity. Also provided are diagnostic methods for detecting nervous system-related disorders and therapeutic methods for treating nervous system-related disorders. Additionally, the present invention is related to methods of treating patients with BAIT polynucleotides or polypeptides, wherein said patients have had seizures or epilepsy.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

Abstract: Human Colon Specific Polynucleotides (DNA and RNA), Polypeptides, and Antibodies, as well as methods for using and producing such polynucleotides, polypeptides, and antibodies are disclosed. More particularly, methods are disclosed for utilizing such polynucleotides, polypeptides, and antibodies to detect, diagnose, prevent, treat, and/or ameliorate cancer (particularly gastrointestinal tract cancers such as colon and pancreatic cancer). Also disclosed are compositions and methods for targeting and destroying cancer cells (particularly gastrointestinal tract cancers such as colon and pancreatic cancer) via the Colon Specific Protein and/or via the Colon Specific Protein Receptor. Moreover, methods of screening for antagonists and binding partners of the Colon Specific Protein and therapeutic uses of such antagonists and binding partners are also disclosed.

Abstract: The present invention provides polynucleotide sequences of the genome of Streptococcus pneumoniae, polypeptide sequences encoded by the polynucleotide sequences, corresponding polynucleotides and polypeptides, vectors and hosts comprising the polynucleotides, and assays and other uses thereof. The present invention further provides polynucleotide and polypeptide sequence information stored on computer readable media, and computer-based systems and methods which facilitate its use.

Abstract: Pharmaceutical compositions consisting essentially of: (a) an adrenergic complement; and (b) a pharmaceutically-acceptable carrier suitable for respiratory administration. Adrenergic complements include ascorbates, tocopherols, and polycarboxylic acid chelators. Methods are also provided for the treatment of respiratory disorders, particularly asthma.

Abstract: The present invention provides polynucleotide sequences of the genome of Staphylococcus aureus, polypeptide sequences encoded by the polynucleotide sequences, corresponding polynucleotides and polypeptides, vectors and hosts comprising the polynucleotides, and assays and other uses thereof. The present invention further provides polynucleotide and polypeptide sequence information stored on computer readable media, and computer-based systems and methods which facilitate its use.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

Abstract: The present invention relates to huXAG-1, huXAG-2 and huXAG-3 proteins which are novel human growth factors. In particular, isolated nucleic acid molecules are provided encoding the huXAG-1, huXAG-2 and huXAG-3 proteins. huXAG-1, huXAG-2 and huXAG-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of huXAG-1, huXAG-2 or huXAG-3 activity. Also provided are diagnostic and therapeutic uses of huXAG-1. huXAG-2 and huXAG-3.

Abstract: The architecture according to the invention is a high service availability Ethernet/IP network architecture, that allows data flows to be conveyed without interruption to service, these flows coexisting with other flows that tolerate interruption to service, and the architecture is characterized in that the network consists of two fault tolerant network architectures that are superposed, one of which is implemented in the form of a single network having a mesh infrastructure and the other in the form of an infrastructure consisting of two independent networks.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

Abstract: The present invention concerns a novel CD44-like protein receptor. In particular, isolated nucleic acid molecules are provided encoding the CD44-like protein. CD44-like polypeptides are also provided, as are screening methods for identifying agonists and antagonists capable of enhancing or inhibiting CD44-like protein-mediated signaling. The invention further concerns therapeutic methods for treating diseases associated with processes mediated by CD44-like protein signaling.

Abstract: Human chemotactic cytokine III polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, auto-immune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever, cerebral ischemia, glomerulonephritis, HTLV-1 related diseases and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides.